endometriosis. endometriosis
Conditions
Interventions
Intervention 1: Intervention group: using daily sildenafil, 100 mg tablet, during 3 days of menstrual cycle. Intervention 2: Control group: using daily placebo tablet, similar to sildenafil, during 3
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: patients with moderate to severe endometriosis suffer from dysmenorrhea, They are between 18 and 45 years old They were diagnosed with ultrasound
Exclusion criteria
Exclusion criteria: People who take nitroglicerine during study People who have used any hormonal medication People with hepatorenal disease People with pelvic pain non relevant to menstural cycle People with pervious MI or CVA People with abnormal blood pressure People with PID People with malignancies People with acute eye problem
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before and 1, 2 and 3 hours after the intervention. Method of measurement: VAS questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| The amount of pain-relieving use during the study. Timepoint: At the end of the study. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Tavoli
Tehran University of Medical Sciencers
Outcome results
None listed